Quidel Corp. | Ownership

Companies that own Quidel Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
T. Rowe Price Associates, Inc.
6,097,695
15.62%
2,046,749
0.06%
06/30/2018
Brown Capital Management LLC
5,390,992
13.81%
-198,982
3.65%
06/30/2018
The Vanguard Group, Inc.
2,709,998
6.94%
323,223
0.01%
06/30/2018
Oracle Investment Management, Inc.
2,364,883
6.06%
28,435
39.97%
06/30/2018
BlackRock Fund Advisors
2,002,840
5.13%
346,813
0.01%
06/30/2018
Fred Alger Management, Inc.
1,157,905
2.97%
80,854
0.34%
06/30/2018
OppenheimerFunds, Inc.
902,018
2.31%
41,789
0.04%
06/30/2018
Dimensional Fund Advisors LP
874,180
2.24%
-50,875
0.02%
06/30/2018
Macquarie Investment Management Business Trust
830,139
2.13%
-272,476
0.12%
06/30/2018
New York State Common Retirement Fund
767,793
1.97%
-43,667
0.07%
06/30/2018

About Quidel

View Profile
Address
12544 High Bluff Drive
San Diego California 92130
United States
Employees -
Website http://www.quidel.com
Updated 07/08/2019
Quidel Corp. engages in the development, manufacture, and market of rapid diagnostic testing solutions. Its portfolio includes immunoassays, molecular diagnostics, virology, and specialty products. Immunoassay tests are for physician offices, hospital laboratories, emergency departments, pharmacies, and other urgent care or alternative site settings.